810 related articles for article (PubMed ID: 25832428)
21. Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways.
Chilvery S; Bansod S; Saifi MA; Godugu C
Int Immunopharmacol; 2020 Nov; 88():106909. PubMed ID: 32882664
[TBL] [Abstract][Full Text] [Related]
22. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
23. Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Balta C; Herman H; Boldura OM; Gasca I; Rosu M; Ardelean A; Hermenean A
Chem Biol Interact; 2015 Oct; 240():94-101. PubMed ID: 26297989
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway.
Wang Y; Zhao L; Jiao FZ; Zhang WB; Chen Q; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):423-429. PubMed ID: 30249543
[TBL] [Abstract][Full Text] [Related]
25. The role of TGF-beta 1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model.
Chen MH; Chen JC; Tsai CC; Wang WC; Chang DC; Tu DG; Hsieh HY
J Ethnopharmacol; 2005 Feb; 97(1):7-13. PubMed ID: 15652268
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory Effect of Corilagin on miR-21-Regulated Hepatic Fibrosis Signaling Pathway.
Zhou X; Xiong J; Lu S; Luo L; Chen ZL; Yang F; Jin F; Wang Y; Ma Q; Luo YY; Wang YJ; Zhou JB; Liu P; Zhao L
Am J Chin Med; 2019; 47(7):1541-1569. PubMed ID: 31752524
[TBL] [Abstract][Full Text] [Related]
27. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways.
Li XM; Peng JH; Sun ZL; Tian HJ; Duan XH; Liu L; Ma X; Feng Q; Liu P; Hu YY
Acta Pharmacol Sin; 2016 Jun; 37(6):783-93. PubMed ID: 27133300
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
29. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW
J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597
[TBL] [Abstract][Full Text] [Related]
30. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
31. EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling.
Park SA; Kim MJ; Park SY; Kim JS; Lee SJ; Woo HA; Kim DK; Nam JS; Sheen YY
Cell Mol Life Sci; 2015 May; 72(10):2023-39. PubMed ID: 25487606
[TBL] [Abstract][Full Text] [Related]
32. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
Tao YY; Wang QL; Shen L; Fu WW; Liu CH
Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
[TBL] [Abstract][Full Text] [Related]
33. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Perumal N; Perumal M; Halagowder D; Sivasithamparam N
Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
[TBL] [Abstract][Full Text] [Related]
34. Suppression of the TGF-β/Smad signaling pathway and inhibition of hepatic stellate cell proliferation play a role in the hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis.
Chen N; Geng Q; Zheng J; He S; Huo X; Sun X
Int J Mol Med; 2014 Oct; 34(4):1110-6. PubMed ID: 25069637
[TBL] [Abstract][Full Text] [Related]
35. TGF-β/Smad and JAK/STAT pathways are involved in the anti-fibrotic effects of propylene glycol alginate sodium sulphate on hepatic fibrosis.
Xu S; Mao Y; Wu J; Feng J; Li J; Wu L; Yu Q; Zhou Y; Zhang J; Chen J; Ji J; Chen K; Wang F; Dai W; Fan X; Guo C
J Cell Mol Med; 2020 May; 24(9):5224-5237. PubMed ID: 32233073
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effects of antigen affinity-purified polyclonal anti-receptor of advanced glycation end-product (RAGE) antibodies on cholestasis-induced liver injury in rats.
Xia P; Deng Q; Gao J; Yu X; Zhang Y; Li J; Guan W; Hu J; Tan Q; Zhou L; Han W; Yuan Y; Yu Y
Eur J Pharmacol; 2016 May; 779():102-10. PubMed ID: 26970185
[TBL] [Abstract][Full Text] [Related]
37. Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-β1/Smad and NFκB signaling.
Hu Z; You P; Xiong S; Gao J; Tang Y; Ye X; Xia Y; Zhang D; Liu Y
Biomed Pharmacother; 2017 Nov; 95():11-17. PubMed ID: 28826091
[TBL] [Abstract][Full Text] [Related]
38. Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways.
Lu ZN; Shan Q; Hu SJ; Zhao Y; Zhang GN; Zhu M; Yu DK; Wang JX; He HW
Bioorg Med Chem; 2021 Nov; 49():116438. PubMed ID: 34610571
[TBL] [Abstract][Full Text] [Related]
39. Epigallocatechin-3-gallate attenuates transforming growth factor-β1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells.
Wang Y; Liu N; Su X; Zhou G; Sun G; Du F; Bian X; Wang B
Biomed Pharmacother; 2015 Mar; 70():260-7. PubMed ID: 25776510
[TBL] [Abstract][Full Text] [Related]
40. TGF-β1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-β1/Smad pathway.
Fang L; Huang C; Meng X; Wu B; Ma T; Liu X; Zhu Q; Zhan S; Li J
Toxicol Appl Pharmacol; 2014 Oct; 280(2):335-44. PubMed ID: 25150141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
